Traditionally, in patients with mitral regurgitation (MR) a successful mitral valve repair is considered when residual MR by post-pump transesophageal echocardiography (TEE) is less than moderate or absent. Little is known about the prognostic value of less than moderate (mild or mild-to-moderate) residual MR for the early outcome of patients treated with mitral valve repair.
Eligible for this study were patients undergoing isolated mitral valve repair. Patients with moderate or severe residual MR after valve repair were excluded. The primary endpoint of the study was the composite of death or need of reintervention.
A total of 98 patients (54 with no residual MR-Group 1, and 44 with less than moderate residual MR-Group 2) were analyzed. Of these, 72% presented with New York Heart Association (NYHA) 3/4, and 38% were women. The primary endpoint of the study occurred in 3 (5.5%) patients in Group 1 and 6 (13.6%) patients in Group 2 MR (P = 0.31). There was a trend toward a higher incidence of use of inotropic drugs post-interventional (P = 0.12), and a longer hospital stay among patients with less than moderate residual MR (P = 0.18).
In our study population, patients with less than moderate residual MR had a trend toward a higher risk of early adverse outcomes as compared with patients with no residual MR by post-pump TEE. Studies with a larger patient population and longer follow-up data may be useful to better define the clinical significance of residual mild MR after mitral vale repair.
Mitral regurgitation is the most commonly encountered valve lesion in modern clinical practice 1. As echocardiography is the most widely available cardiac imaging modality, it is the technique which is routinely used to assess patients with suspected or known MR. Echo-Doppler is an excellent technique for detecting the presence of MR and defining the underlying pathological cause 2. Echo-Doppler grading of regurgitation severity in conjunction with patient symptoms and signs and occasionally invasive haemodynamic information are useful in the decision-making process with respect to the need for and timing of mitral valve surgery 2.
It is important to note that mitral regurgitation changed in the last decades with regard to its etiologic profile, which is now dominated by degenerative and ischemic causes in developed countries 3; to its noninvasive assessment with the developments in transesophageal echocardiography (TEE), colour flow imaging, and new methods of quantization of regurgitation 1; and to its management with improved understanding of the role of left ventricle (LV) function in prognosis 2. Most importantly, advances in conservative surgery have improved its treatment 4.
The post-Cardiac Pulmonary Bypass (CPB) TEE exam is essential in helping to determine the competency of the repaired mitral valve (MV), and to evaluate persistent MR 5. Hemodynamic loading conditions and left ventricle function also must be taken into consideration in the assessment of residual MR 6. Following MV procedures, several studies have suggested that, in approximately 5├óÔé¼ÔÇ£11% of cases the post-CPB TEE exam may identify persistent lesions that require additional immediate surgical intervention 7,8. Moderate to severe residual MR will necessitate a return to CPB for further evaluation and repeat surgery.
The aim of the present retrospective study was to assess the short-term outcome of patients who underwent mitral valve repair in our Cardiac Surgery Division with less than moderate mitral regurgitation after repair.
To collect the necessary information for this study we used the database of patients admitted and treated at Ospedale Pasquinucci, IFC-CNR, Massa, Italy from January 2004 to October 2005./>/>/>/>/>/>/>/>/>/>/>/>/>/>/>/>/>/>/>
- Irvine T, Li XK, Sahn DJ, Kenny A: Assessment of mitral regurgitation. Heart 2002, 88(Suppl 4):11-9.
- Otto CM: Clinical practice. Evaluation and management of chronic mitral regurgitation. N Engl J Med 2001, 345:740-6.
- Olson LJ, Subramanian R, Ackermann DM, Orszulak TA, Edwards WD: Surgical pathology of the mitral valve: a study of 712 cases spanning 21 years. Mayo Clin Proc 1987, 62:22-34.
- Keeffe BG, Otto CM: Mitral regurgitation. Minerva Cardioangiol 2003, 51:29-39.
- Practice guidelines for perioperative transesophagealechocardiography. A report by the American Society of Anesthesiologists and the Society of Cardiovascular Anesthesiologists Task Force on Transesophageal Echocardiography Anesthesiology 1996, 84:986-1006.
- Grewal KS, Malkowski MJ, Piracha AR, Astbury JC, Kramer CM, Dianzumba S, Reichek N: Effect of general anesthesia on the severity of mitral regurgitation by transesophageal echocardiography. Am J Cardiol 2000, 85:199-203.
- Click RL, Abel MD, Schaff HV: Intraoperative transesophageal echocardiography: 5-year prospective review of impact on surgical management. Mayo Clin Proc 2000, 75:241-247.
- Michel-Cherqui M, Ceddaha A, Liu N, Schlumberger S, Szekely B, Brusset A, Bonnet V, Bachet J, Goudot B, Dreyfus G, Guilmet D, Fischler M: Assessment of systematic use of intraoperative transesophageal echocardiography during cardiac surgery in adults: a prospective study of 203 patients. J Cardiothorac Vasc Anesth 2000, 14:45-50.
- Zoghbi WA, Enriquez-Sarano M, Foster E, Grayburn PA, Kraft CD, Levine RA, Nihoyannopoulos P, Otto CM, Quinones MA, Rakowski H, Stewart WJ, Waggoner A, Weissman NJ, American Society of Echocardiography: Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography. J Am Soc Echocardiogr 2003, 16:777-802.
- Fix J, Isada L, Cosgrove D, Miller DP, Savage R, Blum J, Stewart W: Do patients with less than 'echo-perfect' results from mitral valve repair by intraoperative echocardiography have a different outcome? Circulation 1993, 88:39-48.
- Cohn LH, Couper GS, Aranki SF, Rizzo RJ, Adams DH, Collins JJ Jr: The long-term results of mitral valve reconstruction for the floppy" valve. J Card Surg 1994, 9:278-81.
- Cohn LH, Kowalker W, Bhatia S, DiSesa VJ, St John-Sutton M, Shemin RJ, Collins JJ: Comparative morbidity of mitral valve repair versus replacement for mitral regurgitation with and without coronary artery disease. 1988. Updated in 1995. Ann Thorac Surg 1995, 60:1452-3.